Orthofix Medical (OFIX) Cash from Operations (2010 - 2026)

Orthofix Medical has disclosed Cash from Operations across 17 years of filings, most recently posting 17610000.0 for Q1 2026.

• Quarterly Cash from Operations rose 4.25% year-over-year to 17610000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 34128000.0 (up 31.29% YoY) and the FY2025 annual result came in at 33347000.0, up 29.3% from the prior year.
• Cash from Operations fell to 17610000.0 in Q1 2026, from 27697000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 27697000.0 in Q4 2025 and troughed at 34020000.0 in Q1 2023.
• A 5-year average of 927294.12 and a median of 1264000.0 in 2022 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2022 — Cash from Operations tumbled 415.81% — and 2024, when it soared 2346.75%.
• Tracing OFIX's Cash from Operations over 5 years: stood at 2348000.0 in 2022, then slumped by 385.09% to 6694000.0 in 2023, then surged by 454.5% to 23730000.0 in 2024, then advanced by 16.72% to 27697000.0 in 2025, then tumbled by 163.58% to 17610000.0 in 2026.
• Business Quant data shows OFIX's Cash from Operations at 17610000.0 in Q1 2026, 27697000.0 in Q4 2025, and 12402000.0 in Q3 2025.